M K Palmer

4.9k total citations · 1 hit paper
51 papers, 3.9k citations indexed

About

M K Palmer is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, M K Palmer has authored 51 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 12 papers in Surgery and 9 papers in Cancer Research. Recurrent topics in M K Palmer's work include Breast Cancer Treatment Studies (7 papers), Acute Myeloid Leukemia Research (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). M K Palmer is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Acute Myeloid Leukemia Research (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). M K Palmer collaborates with scholars based in United Kingdom, Australia and United States. M K Palmer's co-authors include Jeanne Lythgoe, Ian Hann, G G Ribeiro, P H Morris Jones, D I Evans, Maria Celia B. Hughes, J.C. Brocklehurst, Alan L. Stewart, Martin Schumacher and I. Fogelman and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

M K Palmer

46 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

WHO Handbook for Reporting Results of Cancer Treatment

1982 1.9k citations M K Palmer British Journal of Cancer profile →

Peers

Countries citing papers authored by M K Palmer

Since Specialization

Citations

This map shows the geographic impact of M K Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M K Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M K Palmer more than expected).

Fields of papers citing papers by M K Palmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M K Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M K Palmer. The network helps show where M K Palmer may publish in the future.

Co-authorship network of co-authors of M K Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of M K Palmer. A scholar is included among the top collaborators of M K Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M K Palmer. M K Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacist review of discharge antibiotics for urinary tract infections in the emergency department 2024 ·JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), M K Palmer, (unknown)	0
2	Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) 2003 ·Osteoporosis International ·I. Fogelman, Glen M. Blake, R.W. Blamey, M K Palmer, Willi Sauerbrei, Martin Schumacher, D. Serin, Alan L. Stewart, Wim Wilpshaar	87
3	Clinical determinants of survival in patients with 5-fluorouracil- based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients 2002 ·Annals of Oncology ·C.-H. Köhne, David Cunningham, Francesco Di Costanzo, Bengt Glimelius, G.H. Blijham, Enrique Aranda, Werner Scheithauer, P. Rougier, M K Palmer, J. Wils, B. Barón, Francesco Pignatti, Patrick Schöffski, (unknown), Hartmut Hecker	356
4	Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number 1998 ·European Journal of Cancer ·John Zalcberg, (unknown), Leonard W. Seymour, M K Palmer	95
5	An evaluation of the effectiveness and safety of razoxane when used as an adjunct to surgery in colo-rectal cancer 1993 ·International Journal of Colorectal Disease ·R D Kingston, J W L Fielding, M K Palmer	4
6	Peri-operative heparin: a possible adjuvant to surgery in colo-rectal cancer? 1993 ·International Journal of Colorectal Disease ·R D Kingston, J W L Fielding, M K Palmer	21
7	Thirty-four year follow up of patients with breast cancer in clinical trial of postoperative radiotherapy. 1985 ·BMJ ·M K Palmer, G G Ribeiro	30
8	Clinical Trials: A Pratical Approach. 1985 ·Journal of the Royal Statistical Society Series A (General) ·M K Palmer, Stuart Pocock	0
9	Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG) 1984 ·British Journal of Cancer ·M.G. Mott, J M Chessells, M. L. N. Willoughby, J R Mann, P. H. Morris‐Jones, J. S. Malpas, M K Palmer	35
10	Adjuvant low dose radiation in childhood non-Hodgkin's lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG) 1984 ·British Journal of Cancer ·M.G. Mott, O. B. Eden, M K Palmer	23
11	Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute. 1983 ·BMJ ·G Ribeiro, M K Palmer	40
12	Adjuvant tamoxifen for operable carcinoma of the breast 1983 ·BMJ ·G G Ribeiro, M K Palmer	2
13	Renal size as a prognostic factor in childhood acute lymphoblastic leukemia 1981 ·Cancer ·Ian Hann, P. D. Lees, M K Palmer, Subhash Gupta, P. H. Morris‐Jones	21
14	Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhood 1980 ·British Journal of Cancer ·J H Scarffe, Ian Hann, D I Evans, P. Morris Jones, M K Palmer, J S Lilleyman, D. Crowther	48
15	A score at diagnosis for predicting length of remission in childhood acute lymphoblastic leukaemia 1980 ·British Journal of Cancer ·M K Palmer, Ian Hann, P. Morris Jones, D I Evans	37
16	Lymphocyte function related to survival curves in patients with metastatic melanoma treated by chemoimmunotherapy 1978 ·Medical and Pediatric Oncology ·N. Thatcher, M K Palmer, R. Swindell, D. Crowther	2
17	Breast carcinoma associated with pregnancy: a clinician's dilemma. 1977 ·BMJ ·G G Ribeiro, M K Palmer	48
18	A comparative study for the enumeration of peripheral blood white cell counts below 2.0 x 10(9)/1 using counting chambers and the Coulter Counter model "S". 1977 ·Journal of Clinical Pathology ·(unknown), M K Palmer, Sally Hull	5
19	Panel discussion on glottic tumors. VII. The management of glottic carcinoma by primary irradiation with surgery in reserve 1975 ·The Laryngoscope ·John Stewart, James R. Brown, M K Palmer, (unknown)	47
20	Histologic patterns of neuroblastoma related to prognosis and clinical staging 1974 ·Cancer ·Maria Celia B. Hughes, (unknown), M K Palmer	84

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact